|
|
|
|
|
|
|
14.01.26 - 06:18
|
Sino Biopharm To Remain Active in M&A, Says Chair (Bloomberg)
|
|
|
Sino Biopharmaceutical Chairwoman Theresa Tse says her company is open to acquiring more biotech companies in China after announcing a new buyout. She also tells "Bloomberg: The China Show" that the company is looking for partnerships with bigger multinational firms. (Source: Bloomberg)...
|
|
|
|
|
14.01.26 - 06:12
|
Ascentage: Partnership With Takeda Going Well (Bloomberg)
|
|
|
Dajun Yang, Co-founder, Chairman and CEO at Ascentage Pharma, says he hopes the company's partnership with Takeda on a blood cancer therapy could be ready for commercialization in two years. He speaks on "Bloomberg: The China Show" ahead of his presentation at the JPMorgan Healthcare Conference in San Francisco. (Source: Bloomberg)...
|
|
|
|
|
|
|
|
|
|
|
|
|
14.01.26 - 05:36
|
Former US Diplomat Klein on US-China Relations (Bloomberg)
|
|
|
William Klein, Consulting Partner at FSG Global and former US Diplomat, discusses the outlook for US and China relations and the impact from President Trump's tariffs on Iran's trading partners. He speaks with Stephen Engle from the sidelines of the UBS Greater China Conference in Shanghai. (Source: Bloomberg)...
|
|
|
|
|
|
|
|
|
|
|
14.01.26 - 04:30
|
UBS′ Lo on Asia M&A Landscape for 2026 (Bloomberg)
|
|
|
Samson Lo, Co-Head of M&A Asia Pacific at UBS Global Banking, discusses the outlook and growth for the M&A landscape in Asia. He speaks with Stephen Engle from the sidelines of the UBS Greater China Conference in Shanghai. (Source: Bloomberg)...
|
|
|
|
|
|
|
|
|
|